382 search results found
- January 23, 2025 | MIT News Office
New START.nano cohort is developing solutions in health, data storage, power, and sustainable energy
-
2.28-29.24-Ethics-Quantiscope
Startup Lightening Talk -
Past Deadline: Feb 28, 2023
Speak at the 2023 MIT Health Science Technology Conference (April 4)
speakerLooking for 10 Startups to present during Startup Lighting Talks and participate at the lunch Exhibit on April 4, 2023 at the 2023 MIT Health Science Technology Conference.
-
Past Deadline: Mar 30, 2024
Speak at the 2024 Bioplus Interphex Korea & Japan Seminar
speakerThe Startup Exchange team is looking for 4 Startups to present and exhibit at the two events, In Seoul and Tokyo.
-
Aria Pharmaceuticals
Andrew A. Radin & Andrew M. Radin
- Thu, September 26, 2024 | Conference
2024 MIT Health Science Forum - Startup Exchange Lightning Talks
MIT ILP Industry Meeting CenterThe 2024 MIT Health Science Technology Conference will highlight broad and transformative trends in biology and healthcare, including early-stage discovery, immune cell responses, diagnostics, clinical capabilities, process development, rapid and continuous manufacturing, robotics and automation, and sustainability, all enhanced by artificial intelligence and machine learning technologies. Leading MIT researchers and MIT-connected startups will showcase these advances and discuss their implications for improving human health.
-
Cracking Cancer 2.0 - Lightning Talks
Introduced by Marcus Dahllof, Associate Program Director, MIT Startup Exchange; Cliff Reid, PhD, CEO, Travera; Todd Gierahn, PhD, Cofounder, Honeycomb; Laura Indolfi, PhD, CEO & Cofounder, PanTher Therapeutics; Ulrik Nielsen, PhD, CEO & Cofounder, Torque; Jason Norris, Cofounder, Elektrofi; Patrick Stern, PhD, CEO & Founder, Sextant; Carlos Castro-Gonzalez, PhD, CEO & Cofounder, Leuko Labs; and Alec Nielsen, PhD, Cofounder, Asimov.
-
Past Deadline: Feb 14, 2022
2022 MIT Health Science Technologies Conference
speakerLooking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.
-
12.8.21-DemoDay-Joesph-Azzarelli
Kinovi: Drug-target kinetic binding data for AI-assisted drug discovery -
Oxalys Pharmaceuticals
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
